OS Therapies OSTX
NYSE OSTX
$1.60 +0.00 (+0.00%)
As of: Oct 1, 2026 · 3:59 PM EDT

OS Therapies (OSTX) Change in Interest Receivables (2023 - 2026)

Updated

OS Therapies' Change in Interest Receivables came in at -$472.00 for Q2 2026.

Analysis

OS Therapies (OSTX) Change in Interest Receivables (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, OS Therapies reported Change in Interest Receivables of -$101,399; for FY2024, it came in at -$613,605.

  • Going back by year, Change in Interest Receivables was -$802,479 in FY2023.
  • The Q2 2026 figure represents the highest quarterly Change in Interest Receivables in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Interest Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 OS Therapies 7.73 Mn 7.73 Mn - -472.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -472.00
Mar 31, 2026 -6,372.00
Sep 30, 2024 -94,555.00
Jun 30, 2024 -269,025.00
Mar 31, 2024 -250,025.00
Dec 31, 2023 -94,300.00
Sep 30, 2023 -371,640.00
Jun 30, 2023 -153,754.00
Mar 31, 2023 -182,785.00
API Access

OS Therapies Change in Interest Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-interest-receivables&ticker=OSTX&period=max&api_key=YOUR_API_KEY